] i but did result in an elevation of basal levels of nearly the the endoplasmic reticulum (Chen et al., 1986) . Increased PI same magnitude 18 hr postexposure. However, anti-IgM-induced breakdown and calcium elevation have also been observed calcium transients were similar in the presence or absence of in antigen-specific B-cells after administration of the antigen TCDD. TCDD exposure also produced instability of the calcium (Grupp et al., 1987; Wilson et al., 1987) . PI signaling events concentration curve, with the observed elevation of basal intracel-in B-cells can be recapitulated by the combination of direct PKC activators (phorbol esters) and calcium ionophores, which elevate intracellular free calcium (Rothstein et al., 
B-cells cultured in low extracellular calcium medium do not Thapsigargin, an immunosuppressive agent, produces a similar effect. In this report, we have compared both the effects proliferate normally in response to antigen receptor crossof TCDD and thapsigargin on B-cell intracellular calcium linking (Dennis et al., 1987) , arguing that calcium elevation as well as the actions of TCDD on the IgM secretory replays a necessary role in the proliferative response to sIg sponses of B-cells stimulated by either anti-IgM (T-indepenligation. dent stimulus) or activated T H -cells expressing CD40 ligand TCDD, a halogenated aromatic hydrocarbon (HAH) and (T-dependent stimulus) plus lymphokines. TCDD was found an environmentally persistent contaminant known to have to selectively suppress anti-IgM-but not CD40 ligand-stimubeen present in Agent Orange, has been shown to be an lated IgM secretion. Since surface Ig but not CD40 ligation immunomodulatory agent capable of inducing thymic atroinduced calcium mobilization, we monitored the effect of phy (Vos et al., 1980; Thomas and Faith, 1985;  Luster et TCDD on intracellular calcium levels in B-cells. Compared al., 1987) and suppressing humoral immune responses due to the ER calcium-ATPase inhibitor thapsigargin, TCDD to an apparent disruption of the differentiative process of Bexposure induced a delayed elevation of basal intracellular lymphocytes (Holsapple et al., 1986; Tucker et al., 1986;  calcium concentration of nearly equal magnitude, suggesting Dooley and Luster et al., 1988) . TCDD that disruption of calcium homeostasis may be a mechanism has recently been shown also to inhibit B-cell proliferative by which TCDD induces suppression of Ig secretion stimuresponses triggered by either surface Ig cross-linking or the lated by signals initiated through surface Ig. combination of PMA plus calcium ionophore (Karras and Holsapple, 1994) . The molecular mechanisms responsible
MATERIALS AND METHODS
for these activities are poorly understood, although binding to the cytoplasmic Ah receptor (so named because this recepAnimals. (C57BL/6 1 C3H)F1 (B6C3F1) female mice were obtained tor, in its activated state, induces transcription of genes from the National Cancer Institute (Frederick, MD) . The care and use of which segregate with the Ah locus) is believed to mediate these animals conformed to the policies and regulations of the Institutional at least some of the biological responses to TCDD (Poland Animal Care and Use Committee. and Knutson, 1982; Whitlock, 1987) . TCDD-induced alterChemicals and animal dosing regimen. 2,3,7,8-tetrachlorodibenzo-pdioxin used for in vivo treatments was obtained through the National Toxiations in calcium homeostasis have been reported in noncology Program and Bio-Rad Laboratories (Rockville Centre, NY) and was lymphoid tissues, including murine hepatoma cells, guinea kept as a 100 mg/ml solution in corn oil. TCDD used for in vitro experiments pig hepatocytes, and guinea pig papillary muscle (Al-Bayati was obtained from Chemsyn Science Laboratories (Lexena, KS) and stock et Canga et al., 1988; Puga et al., 1992) . Previous solutions were dissolved in 100% dimethyl sulfoxide (DMSO). The purity studies have indicated that TCDD-mediated inhibition of B-was found to be §98%, as determined by Chemsyn, using gas chromatography/mass spectrometry. No contaminating dibenzofurans were detected. cell responses to antigen receptor stimulation (1) requires DMSO was purchased from Sigma (St. Louis, MO), and thapsigargin was early addition (i.e., within the first 24 hr of culture with obtained from LC Laboratories (Waltham, MA). For in vivo studies, mice antigen; Tucker et al., 1986) , (2) is not the result of aberrant were administered, by oral gavage, a single dose of 0.2 ml of either corn PI metabolism (Luster et al., 1988) , and (3) could be modu-oil (vehicle) or TCDD (0.3-30.0 mg/kg), in corn oil. Animals were sacrificed 72 hr later to allow for disposition of TCDD and to minimize the lated by calcium ionophore (Karras and Holsapple, 1994) . effects of gavage handling. B-cells were purified from these animals as Despite the recognized role of calcium in B-cell intracelludescribed below. lar signaling events requisite for the proliferative response, Reagents. Goat anti-mouse IgM, F(ab) 2 , was purchased from Jackson the effect of TCDD on B-cell calcium fluxes or compartmen-Immunoresearch (West Grove, PA). The same antibody was also insolubitalization has not been studied. The discovery of thapsigargin lized on Sepharose 4B, as described below. Recombinant murine IL-2, -4, and -5 were purchased from Genzyme (Cambridge, MA). Concanavalin A- (Christensen and Schaumburg, 1983 ; Christensen and stimulated rat T-cell supernatant was obtained from Collaborative Biochem- Norup, 1985) , a sesquiterpene lactone, has provided a tool icals. Anti-CD3-activated and paraformaldehyde-fixed T H 2-cells (CDC.35) with which to study calcium flux and compartmentalization were the generous gift of Dr. David Parker (University of Massachusetts, in cells. Thapsigargin is believed to liberate stored calcium Worcester, MA). Pokeweed mitogen was purchased from Gibco (Grand Island, NY). FITC-conjugated rat anti-mouse Thy 1.2 and goat anti-mouse from the endoplasmic reticulum (ER) by a specific inhibition Ig L3T4 and Lyt-2 were purchased from Becton-Dickinson (San Jose, CA).
of the ER calcium-ATPase (Thastrup et al., 1989) , resulting FITC-conjugated hamster anti-mouse CD3-e was obtained from Pharmingen in an increase in resting intracellular calcium concentrations (San Diego, CA (Krieger et al., 1995) and inhibition of SERCAs by PAHs sapple, 1991). Splenocyte preparations were depleted of macrophages by correlates with the ability of many PAHs to maintain a sus-overnight adherance in RPMI 1640 containing 5% newborn calf serum.
Red blood cells were lysed by Gey's solution and T-cells removed by tained elevation of intracellular calcium in lymphocytes.
incubation with anti-Thy 1.2 (HO-13) plus complement. The remaining pernatants were collected on Day 6 and immediately assayed for immunoglobulin content. Spectrophotometric detection of absorbance changes was cells were separated on discontinuous Percoll (Pharmacia) step gradients using previously established methods (DeFranco et al., 1982; Layton et al. , monitored at 405 nm using a Bio-Rad Model 2550 EIA plate reader. Data were calculated using linear regression analysis of the samples, using a 1985 ; Monroe, 1988) . Cells banding at the 1.079/1.070 (56/50% Percoll) interface, previously shown to be susceptible to TCDD-mediated immunosemilog plot of log mg IgM myeloma protein standard/well versus absorbance. Sensitivity was typically õ10 ng/ml. suppression (Morris et al., 1993) , were collected and used in all experiments. FACScan analysis of this cell population was carried out as described Insolubilizing IgM on Sepharose. For experiments with insolubilized (Morris and Holsapple, 1991) and found to be §98% Ig / and õ1% L3T4/ F(ab) 2 anti-IgM, the antibody was coupled to cyanogen bromide-activated Lyt-2 / . Macrophage and granulocyte contamination was monitored by Sepharose-4B (Sigma). Briefly, the Sepharose beads were swelled with 1 Wright-Giemsa-stained cytocentrifuge preparations and found to be õ1%. mM HCl and pelleted by centrifugation. An appropriate amount of antiCell culture media. All experiments were performed in RPMI 1640 IgM to give a 1 mg/ml final concentration was added and the slurry was (Gibco) containing 2 mM L-glutamine, 1% (v/v) penicillin-streptomycin mixed on an automatic vortex at the lowest speed at 4ЊC for 18 hr. The (Sigma) solution, and 5 1 10 05 M 2-mercaptoethanol and supplemented slurry was washed with borate-buffered saline (BBS), pH 8.0, and the with 5% newborn calf serum (Flow Laboratories).
percentage of unbound antibody was determined by spectrophotometry. Measurement of intracellular calcium. Intracellular calcium in naive Unbound active sites were then blocked by mixing on the vortex with an (untreated), vehicle-(0.01% DMSO in vitro or corn oil in vivo), TCDD-equal volume of 2 M ethanolamine, pH 9.0, for 2 hr at room temperature. (0.3-30.0 nM in vitro or 0.3-30.0 mg/kg in vivo), or thapsigargin (0.3-The slurry was washed two times with BBS, then once with PBS, pH 7.0, 30.0 nM) treated B-cells cultured with or without anti-IgM (either soluble and resuspended in PBS in the appropriate volume to yield a 1 mg/ml or insolubilized), pokeweed mitogen, or activated T H 2-cells was measured concentration of bound anti-IgM. using a modified version of a previously described method (Yellen et al., Statistical analysis. Results were analyzed using a one-way analysis of 1991). B-cells freshly isolated from spleens of naive, vehicle-, or TCDD-variance. When treatment effects were observed, a Dunnett's T test was dosed animals or harvested from vehicle-, TCDD-, or thapsigargin-treated used to specify which treatment groups were significantly different from cultures were washed and resuspended at 1 1 10 7 /ml in HBSS containing controls, except for the analysis of intracellular calcium, for which the 1 mM CaCl 2 , 20 mM Hepes buffer, and 5% newborn calf serum. Fura-2 Duncan multiple range test was used. acetoxymethylester (Calbiochem Corp., La Jolla, CA) was added to the cells at a final concentration of 4 nM and mixed. Under subdued lighting
RESULTS
conditions, the cells were rotated at room temperature for 10 min, washed, resuspended as above in HBSS, and incubated with occasional mixing at 37ЊC for 15 min. The cells were then washed and adjusted to 2.5 1 10 7 / TCDD Suppresses IgM Secretion Induced by Soluble or ml and 200 ml of cell suspension was added to 1.8 ml of prewarmed
Insolubilized Anti-IgM Plus Lymphokines
HBSS containing 1% newborn calf serum in a quartz cuvette. Calcium measurements were made using a SPEX dual-excitation spectrofluorometer To determine the basis for the TCDD-induced suppression with excitation wavelengths set at 340 and 380 nm and emission monitored of the humoral immune response, we set out to examine the at 505 nm. Maximum and minimum fluorescence ratios were determined effects of TCDD on B-cell differentiation triggered by stimafter each run by addition of 10% Triton X-100 and 0.5 M EGTA in 3 M uli that mediate their effects via two separate receptors on Tris buffer, respectively. Fluorescence ratios were converted to calcium concentrations using SPEX software. B-cells: the antigen receptor and CD40. sIg cross-linking Analysis of B-cell proliferation. B-cell proliferative responses were using anti-IgM mimics the B-cell response to a T-independetermined using 2.5 1 10 5 isolated B-cells/well for anti-IgM or 2 1 10 5 / dent antigen with repeating antigenic epitopes. Activated T Hwell for LPS and PMA plus ionomycin responses in 96-well flat-bottom cells expressing CD40 ligand represent a model with which plates (Costar). Medium (NA), 0.01% DMSO (VH), or thapsigargin (0.3-to study activation signals delivered to B-cells by antigen-30.0 nM in 0.01% DMSO) was preincubated for 18 hr before addition of stimuli for convenience; treatment effects were also observed after shorter stimulated T-cells, as would be provided during contact with incubations (data not shown). Soluble and insolubilized anti-IgM and LPS a T-dependent antigen.
were added at 10 mg/ml, PMA was added at 100 ng/ml, and ionomycin After B-cells were incubated with either soluble or insoluwas added at 400 ng/ml. [ of IL-2, -4, and -5 for secretion of IgM. In contrast to the suppression of IgM secretion by TCDD following stimulation through sIg, TCDD failed to suppress IgM secretion induced by CD40 ligation in the presence of lymphokines (Fig. 2) . Since TCDD has been shown to suppress the plaque-forming cell response to the T-dependent antigen SRBC, this result is intriguing and suggests that the T-cell signal may be perceived differently by the B-cell if it has first encountered protein antigen (i.e., antigen specific response versus bystander response).
sIgM but Not CD40 Ligation Induces Calcium Mobilization in Isolated B-Cells
Because sIg-but not CD40-stimulated B-cell differentiation was inhibited by TCDD, the calcium mobilization responses of the stimuli acting through these sites were compared. As shown in fixed, whole cells, or as membrane-enriched fractions thereof, stimulate contact-dependent B-cell cycle entry (Bartlett et al., 1990; Hodgkin et al., 1990) . In the presence of IL-4, strong proliferation is induced and, upon addition of IL-2 and IL-5, secretion of Ig of all isotypes can be measured (Bartlett et al., 1990; Hodgkin et al., 1990) . Further work indicated that this inducible T-cell help is transient in nature, independent of antigen or MHC class II restriction noticeable changes in intracellular calcium levels. Isolated after either thapsigargin or TCDD exposure (each at 30 nM)
shows that intracellular calcium is significantly increased in B-cells also do not mobilize calcium in response to the Tcell-dependent polyclonal B-cell activator, pokeweed mito-cells after thapsigargin but not TCDD treatment (Table 1) .
However, analysis of intracellular calcium content at 18 hr gen (PWM). Interestingly, like activated T H -cell-stimulated responses, TCDD also does not suppress B-cell responses postexposure shows that a dose-dependent elevation is induced by both compounds (Table 1) . At identical concentrastimulated by PWM (Wood et al., 1992) . tions (i.e., 0.3-30.0 nM), thapsigargin induces a slightly more potent response than that observed with TCDD. Thus,
Elevation of B-Cell Resting Intracellular Calcium Levels although both thapsigargin and TCDD treatments of B-cells after TCDD or Thapsigargin Exposure
result in increased resting intracellular calcium concentraThapsigargin (30 nM), dissolved in DMSO and added di-tions, differences in both the kinetics and the magnitude of rectly to isolated B-cells, produces an immediate increase these elevations are notable. These results suggest that of approximately 1.5-fold in intracellular calcium, followed TCDD and thapsigargin may act through different mechaby a constant rise which reaches micromolar concentrations nisms to elevate intracellular calcium in isolated primary Bat about 2.5 min (Fig. 4A ). This dynamic increase in intracel-cells. lular calcium concentration triggers spiking fluctuations of large magnitude shortly thereafter.
Direct addition of 30 nM Elevation of B-Cell Resting Intracellular Calcium Levels TCDD in DMSO to isolated B-cells produced a similar imby TCDD Occurs after Either in Vitro or in Vivo mediate increase in calcium, but no further elevation up to
Exposure but Does Not Prevent Anti-IgM-Mediated 5 min after addition (Fig. 4B ). Later addition of the DMSO Calcium Mobilization vehicle alone, during the same trial, also produced a similar rise in intracellular calcium, suggesting that this modest inTo study the effects of elevated intracellular calcium levels on early B-cell signaling responses mediated through the crease is the result of addition of the DMSO vehicle (Fig.  4B) . In similar experiments, TCDD did not produce in-antigen receptor, analysis of the effect of TCDD on calcium mobilization induced by soluble F(ab) 2 anti-IgM was percreases in intracellular calcium over the first 30 min after treatment (data not shown).
formed. These experiments were conducted using both 18 hr in vitro (Fig. 5A ) and 72 hr in vivo (Fig. 5B ) TCDD Examination of B-cell intracellular calcium levels 1 hr magnitude of the observed fluctuations increased in a dosedependent fashion (data not shown).
Thapsigargin Inhibits B-Cell Responses to LPS and Soluble Anti-IgM but Superinduces the B-Cell Response to PMA Plus Ionomycin
Thapsigargin has been shown to induce histamine release and increases in intracellular calcium concentrations in platelets (Thastrup et al., 1987) , as well as elevated intracellular calcium in other cell types (Christensen and Schaumburg, 1983; Christensen and Norup, 1985; Thastrup et al., 1989) . Because, like TCDD, thapsigargin produces increases in intracellular calcium levels in isolated B-cells, its effects on B-cell responsiveness were studied. Thapsigargin preincubation for 18 hr potently inhibits both LPS-and soluble antiIgM-stimulated B-cell proliferation (Fig. 6) , as well as LPSstimulated IgM secretion (significant suppression at 3.0 nM; data not shown). Interestingly, low concentrations of thapsigargin (0.3-3.0 nM) superinduce the B-cell proliferative response to PMA plus ionomycin, while higher concentrations (30.0 nM) inhibit it (Fig. 6 ). This is a different profile of activity than that observed with TCDD, which inhibits PMA using the in vitro TCDD treatment regimen showed that the lized anti-IgM was used instead of the soluble form. However, Ig responses triggered by activated T H -cells expressing CD40 ligand were refractory to TCDD preexposure. Because sIg cross-linking with anti-IgM antibodies induces calcium mobilization, the effects of TCDD on B-cell calcium levels were assessed. While anti-IgM-stimulated calcium mobilization occurred normally after TCDD exposure, basal intracellular calcium levels were substantially elevated by TCDD. Interestingly, another environmental chemical, dimethylbenz(a)anthracene (DMBA), also appears to disturb lymphocyte calcium management (Archuleta et al., 1993) .
Calcium is a primary intracellular signaling messenger which plays a critical role in B-cell activation mediated by sIg. Since cells maintain a large calcium gradient across their plasma membranes, using energy-requiring pumps to either extrude or sequester it from their cytoplasm, it is not surprising that compounds which modulate intracellular calcium would affect B-cell function. However, the results shown here suggest that B-cells responding to stimulation via CD40 alone, in the absence of antigen, are not as sensitive to elevation of intracellular calcium as their sIg-activated counterparts. This result is in keeping with the lack of a detectable calcium signal in purified murine B-cells stimulated through CD40 by fixed and activated T H 2-cells (Fig. 3) . A similar observation was made earlier using an anti-CD40 mono- plus ionomycin-induced B-cell proliferation over a concentration range from 0.3 to 30.0 nM (Karras and Holsapple, 1994) . These data suggest that the opposing effects of TCDD and thapsigargin on this response may reflect the different kinetic profiles of calcium mobilization by these compounds. stage of the immune response. In this report, we have comStimuli were added as indicated, and [ antibody preparation, no calcium transients were observed well as papillary muscle cells (Al-Bayati et al., 1988; Canga et al., 1988; Puga et al., 1992) , and some of these effects up to 30 min after addition of the activated T-cells (author's unpublished observations). More importantly, the data sug-have been shown to be Ah receptor independent (Puga et al., 1992) . Although it is as yet unknown if the effects of gest that the signal that is sensitive to TCDD in the Tdependent antibody response is provided by antigen and not TCDD on B-cell resting Ca 2/ levels are Ah receptor dependent, together these results, along with those presented here, by subsequent T-cell help. support a role for disruption of calcium homeostasis as a Identification of the signaling machinery utilized after common mechanism for TCDD toxicity. CD40 ligation has been elusive; however, it appears that early calcium mobilization is not important for CD40 func-
In vitro concentrations of TCDD of 3-30 nM were required in these studies to observe significant suppression tional responses in vitro. In contrast, anti-Ig-stimulated antibody response models are affected by elevations in intracel-of antibody responses and elevation of intracellular Ca 2/ . However, only a small portion of the TCDD added is associlular calcium concentrations of two-to threefold over baseline. The effect of TCDD on proliferative and differentiative ated with the cultured cells. Our previous in vitro disposition studies with [ 3 H]TCDD showed that the vast majority of responses to anti-Ig is not manifest on Ia expression stimulated by this mitogen (Karras and Holsapple, 1994) , indicat-TCDD added to the cultures binds to the plastic culture wells and partitions to the medium rather than to the cells. ing that calcium is not involved in all B-cell responses to these stimuli. Recent reports support these observations: Calculation of the concentration of TCDD in the cell fraction shows that only 2-3 fM associates with the cells after expoKlaus and Parker have shown that B-cell signaling pathways for T-dependent activation of B-cells are qualitatively differ-sure to a 10 nM dose (Morris et al., 1993) . This observation is in good agreement with the amount of TCDD associated ent from those for activation through sIg, with regard to the profile of immediate early genes that are expressed (Klaus with lymphoid tissues following a 5 mg/kg in vivo dose (Neumann et al., 1992). and Parker, 1992) . In addition, PKC and cAMP agonists, which potently inhibit anti-Ig proliferation of B-cells, do not Thapsigargin has previously been shown to provoke proinhibit activated T H -cell-mediated responses (Kawakami and nounced increases in intracellular calcium levels in various Parker, 1992).
tissues, including human platelets and peripheral blood lymphocytes (Thastrup et al., 1987; , due While the magnitude of the immediate calcium mobilization response of Sepharose-coupled anti-IgM is lower than to discharge of intracellularly sequestered calcium (Thastrup et al., 1989) . The slow kinetics of calcium elevation after that of soluble anti-IgM (Fig. 3) , the duration of this response is protracted. This observation suggests that the intensity of TCDD exposure (compared to thapsigargin) may explain the prior observation that immunomodulation by TCDD requires the stimulatory signal delivered through sIg is related to the length of time that [Ca 2/ ] i is elevated rather than the magni-its addition at or near the time of B-cell stimulation (Holsapple et al., 1986; Tucker et al., 1986) . These kinetics also tude of the immediate calcium peak. TCDD suppresses the antibody response triggered by each of these stimuli equally, suggest that the TCDD-sensitive processes of B-cell activation and differentiation may not manifest until hours after suggesting that a common site of action may be downstream kinases or signaling elements activated by calcium fluxes. stimulation. TCDD has been reported to induce apoptosis in thymocytes via activation of a calcium-dependent endonu-TCDD treatment has been reported to activate kinase activity in B-cells (Kramer et al., 1987; Clark et al., 1991) . The clease (McConkey et al., 1988) . However, no changes in viability were evident after TCDD exposure in 6-day antirelationship between increased levels of intracellular calcium and activation of B-cell kinases by TCDD is unknown but body response cultures (author's unpublished observations).
The respective effects of TCDD and thapsigargin on B-cells has been the focus of a significant amount of speculation (Matsumura, 1994) . may also be determined by calcium-independent pathways, perhaps some shared and some not, since it is not clear Much interest has recently focused on determining the whether these compounds have other activities in addition mechanism(s) of the TCDD-mediated interference of B-cell to calcium mobilization. function. The results reported here, together with previous data, suggest that TCDD inhibits B-cell signaling pathways
The differences in the B-cell response to PMA plus ionomycin after thapsigargin or TCDD exposure suggest that which involve rapid calcium mobilization. Specifically, Bcell responses to anti-IgM, PMA plus ionomycin (Karras the pattern of calcium release determines how this signal is perceived by the cell. The thapsigargin calcium response in and Holsapple, 1994) , and LPS (Morris et al., 1993) have been shown to be suppressed by TCDD while stimuli which B-cells kinetically resembles that of ionomycin, while that of TCDD is more protracted. With regard to the source of do not appear to induce rapid B-cell calcium flux, such as activated T H -cells and PWM, were not affected. TCDD has calcium from which flux occurs after TCDD treatment, it appears that calcium influx is not responsible for the accumupreviously been shown to alter calcium homeostasis in other cell types, including hepatocytes and hepatoma cell lines, as lation, due to our inability in preliminary studies to document
